Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Fascin Controls Metastatic Colonization and Mitochondrial Oxidative Phosphorylation by Remodeling Mitochondrial Actin Filaments.

Lin S, Huang C, Gunda V, Sun J, Chellappan SP, Li Z, Izumi V, Fang B, Koomen J, Singh PK, Hao J, Yang S.

Cell Rep. 2019 Sep 10;28(11):2824-2836.e8. doi: 10.1016/j.celrep.2019.08.011.

2.

HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma.

Faião-Flores F, Emmons MF, Durante MA, Kinose F, Saha B, Fang B, Koomen JM, Chellappan SP, Maria-Engler SS, Rix U, Licht JD, Harbour JW, Smalley KSM.

Clin Cancer Res. 2019 Sep 15;25(18):5686-5701. doi: 10.1158/1078-0432.CCR-18-3382. Epub 2019 Jun 21.

PMID:
31227503
3.

Cationic lipoplexes for treatment of cancer stem cell-derived murine lung tumors.

Andey T, Bora-Singhal N, Chellappan SP, Singh M.

Nanomedicine. 2019 Jun;18:31-43. doi: 10.1016/j.nano.2019.02.007. Epub 2019 Mar 1.

PMID:
30831275
4.

Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.

Schaal CM, Bora-Singhal N, Kumar DM, Chellappan SP.

Mol Cancer. 2018 Oct 15;17(1):149. doi: 10.1186/s12943-018-0901-2.

5.

ChIP on chip and ChIP-Seq assays: genome-wide analysis of transcription factor binding and histone modifications.

Pillai S, Chellappan SP.

Methods Mol Biol. 2015;1288:447-72. doi: 10.1007/978-1-4939-2474-5_26.

PMID:
25827896
6.

Chromatin immunoprecipitation assays: analyzing transcription factor binding and histone modifications in vivo.

Pillai S, Dasgupta P, Chellappan SP.

Methods Mol Biol. 2015;1288:429-46. doi: 10.1007/978-1-4939-2474-5_25.

PMID:
25827895
7.

In vitro replication assay with mammalian cell extracts.

Rizwani W, Chellappan SP.

Methods Mol Biol. 2015;1288:349-62. doi: 10.1007/978-1-4939-2474-5_20.

PMID:
25827890
8.

Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC.

Perumal D, Pillai S, Nguyen J, Schaal C, Coppola D, Chellappan SP.

Oncotarget. 2014 Nov 15;5(21):10486-502.

9.

The Rb-E2F transcriptional regulatory pathway in tumor angiogenesis and metastasis.

Schaal C, Pillai S, Chellappan SP.

Adv Cancer Res. 2014;121:147-182. doi: 10.1016/B978-0-12-800249-0.00004-4. Review.

PMID:
24889531
10.

Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers.

Schaal C, Chellappan SP.

Mol Cancer Res. 2014 Jan;12(1):14-23. doi: 10.1158/1541-7786.MCR-13-0541. Epub 2014 Jan 7. Review.

11.

Selective disruption of rb-raf-1 kinase interaction inhibits pancreatic adenocarcinoma growth irrespective of gemcitabine sensitivity.

Treviño JG, Verma M, Singh S, Pillai S, Zhang D, Pernazza D, Sebti SM, Lawrence NJ, Centeno BA, Chellappan SP.

Mol Cancer Ther. 2013 Dec;12(12):2722-34. doi: 10.1158/1535-7163.MCT-12-0719. Epub 2013 Oct 9.

12.

βArrestin-1 and Mcl-1 modulate self-renewal growth of cancer stem-like side-population cells in non-small cell lung cancer.

Singh S, Bora-Singhal N, Kroeger J, Laklai H, Chellappan SP.

PLoS One. 2013;8(2):e55982. doi: 10.1371/journal.pone.0055982. Epub 2013 Feb 13.

13.

Nicotine induces inhibitor of differentiation-1 in a Src-dependent pathway promoting metastasis and chemoresistance in pancreatic adenocarcinoma.

Treviño JG, Pillai S, Kunigal S, Singh S, Fulp WJ, Centeno BA, Chellappan SP.

Neoplasia. 2012 Dec;14(12):1102-14.

14.

Regulation of interlocking gene regulatory network subcircuits by a small molecule inhibitor of retinoblastoma protein (RB) phosphorylation: cancer cell expression of HLA-DR.

Pillai S, Szekeres K, Lawrence NJ, Chellappan SP, Blanck G.

Gene. 2013 Jan 10;512(2):403-7. doi: 10.1016/j.gene.2012.09.092. Epub 2012 Oct 3.

PMID:
23041127
15.

EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.

Singh S, Trevino J, Bora-Singhal N, Coppola D, Haura E, Altiok S, Chellappan SP.

Mol Cancer. 2012 Sep 25;11:73. doi: 10.1186/1476-4598-11-73.

16.

A novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLC.

Perumal D, Singh S, Yoder SJ, Bloom GC, Chellappan SP.

PLoS One. 2012;7(8):e43589. doi: 10.1371/journal.pone.0043589. Epub 2012 Aug 29.

17.

Genetic and biochemical alterations in non-small cell lung cancer.

Johnson JL, Pillai S, Chellappan SP.

Biochem Res Int. 2012;2012:940405. doi: 10.1155/2012/940405. Epub 2012 Aug 15.

18.
19.

IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer.

Guo J, Kim D, Gao J, Kurtyka C, Chen H, Yu C, Wu D, Mittal A, Beg AA, Chellappan SP, Haura EB, Cheng JQ.

Oncogene. 2013 Jan 10;32(2):151-9. doi: 10.1038/onc.2012.39. Epub 2012 Feb 13.

20.

Nicotine-mediated induction of E-selectin in aortic endothelial cells requires Src kinase and E2F1 transcriptional activity.

Alamanda V, Singh S, Lawrence NJ, Chellappan SP.

Biochem Biophys Res Commun. 2012 Feb 3;418(1):56-61. doi: 10.1016/j.bbrc.2011.12.127. Epub 2012 Jan 3.

21.

TNF-α-mediated proliferation of vascular smooth muscle cells involves Raf-1-mediated inactivation of Rb and transcription of E2F1-regulated genes.

Davis R, Pillai S, Lawrence N, Sebti S, Chellappan SP.

Cell Cycle. 2012 Jan 1;11(1):109-18. doi: 10.4161/cc.11.1.18473. Epub 2012 Jan 1.

22.

The Jab1-E2F1 interaction: a matter of life and death.

Chellappan SP.

Cell Cycle. 2011 Dec 1;10(23):3996-7. doi: 10.4161/cc.10.23.18355. Epub 2011 Dec 1. No abstract available.

PMID:
22134136
23.

Regulation of matrix metalloproteinase genes by E2F transcription factors: Rb-Raf-1 interaction as a novel target for metastatic disease.

Johnson JL, Pillai S, Pernazza D, Sebti SM, Lawrence NJ, Chellappan SP.

Cancer Res. 2012 Jan 15;72(2):516-26. doi: 10.1158/0008-5472.CAN-11-2647. Epub 2011 Nov 15. Erratum in: Cancer Res. 2012 Mar 1;72(5):1317.

24.

TNF-α response of vascular endothelial and vascular smooth muscle cells involve differential utilization of ASK1 kinase and p73.

Rastogi S, Rizwani W, Joshi B, Kunigal S, Chellappan SP.

Cell Death Differ. 2012 Feb;19(2):274-83. doi: 10.1038/cdd.2011.93. Epub 2011 Jul 8.

25.

ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors.

Dasgupta P, Rizwani W, Pillai S, Davis R, Banerjee S, Hug K, Lloyd M, Coppola D, Haura E, Chellappan SP.

J Natl Cancer Inst. 2011 Feb 16;103(4):317-33. doi: 10.1093/jnci/djq541. Epub 2011 Jan 6.

26.

CDKN1C negatively regulates RNA polymerase II C-terminal domain phosphorylation in an E2F1-dependent manner.

Ma Y, Chen L, Wright GM, Pillai SR, Chellappan SP, Cress WD.

J Biol Chem. 2010 Mar 26;285(13):9813-22. doi: 10.1074/jbc.M109.091496. Epub 2010 Jan 27.

27.

In vitro replication assay with mammalian cell extracts.

Rizwani W, Chellappan SP.

Methods Mol Biol. 2009;523:203-16. doi: 10.1007/978-1-59745-190-1_14.

PMID:
19381937
28.

Chromatin immunoprecipitation assays: analyzing transcription factor binding and histone modifications in vivo.

Pillai S, Dasgupta P, Chellappan SP.

Methods Mol Biol. 2009;523:323-39. doi: 10.1007/978-1-59745-190-1_22.

PMID:
19381928
29.

ChIP on chip assays: genome-wide analysis of transcription factor binding and histone modifications.

Pillai S, Chellappan SP.

Methods Mol Biol. 2009;523:341-66. doi: 10.1007/978-1-59745-190-1_23.

PMID:
19381927
30.

Chromatin immunoprecipitation assays: molecular analysis of chromatin modification and gene regulation.

Dasgupta P, Chellappan SP.

Methods Mol Biol. 2007;383:135-52. doi: 10.1007/978-1-59745-335-6_9.

PMID:
18217683
31.

Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story.

Dasgupta P, Chellappan SP.

Cell Cycle. 2006 Oct;5(20):2324-8. Epub 2006 Oct 16. Review.

PMID:
17102610
32.

Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites.

Joshi B, Rastogi S, Morris M, Carastro LM, DeCook C, Seto E, Chellappan SP.

Biochem J. 2007 Jan 1;401(1):155-66.

33.

Regulation of neuron survival and death by p130 and associated chromatin modifiers.

Liu DX, Nath N, Chellappan SP, Greene LA.

Genes Dev. 2005 Mar 15;19(6):719-32.

34.

Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis.

Dasgupta P, Sun J, Wang S, Fusaro G, Betts V, Padmanabhan J, Sebti SM, Chellappan SP.

Mol Cell Biol. 2004 Nov;24(21):9527-41.

35.

A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis.

Joshi B, Ko D, Ordonez-Ercan D, Chellappan SP.

Biochem Biophys Res Commun. 2003 Dec 12;312(2):459-66.

PMID:
14637159
37.

Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression.

Wang S, Fusaro G, Padmanabhan J, Chellappan SP.

Oncogene. 2002 Dec 5;21(55):8388-96.

38.

HOG on the promoter: regulation of the osmotic stress response.

Chellappan SP.

Sci STKE. 2001 Jul 31;2001(93):pe1. Review.

PMID:
11752666
39.

Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.

Gewirtz DA, Di YM, Randolph JK, Jain PT, Valerie K, Bullock S, Nath N, Chellappan SP.

Arch Biochem Biophys. 2001 Apr 15;388(2):243-52.

PMID:
11368161
40.
41.
42.
43.
44.

Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.

Chellappan SP, Giordano A, Fisher PB.

Curr Top Microbiol Immunol. 1998;227:57-103. Review. No abstract available.

PMID:
9479826
45.

Effects of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation and drug-mediated apoptosis in human myeloid leukemia cells (HL-60).

Freemerman AJ, Vrana JA, Tombes RM, Jiang H, Chellappan SP, Fisher PB, Grant S.

Leukemia. 1997 Apr;11(4):504-13.

46.

Genomic cloning and chromosomal assignment of the E2F dimerization partner TFDP gene family.

Zhang Y, Venkatraj VS, Fischer SG, Warburton D, Chellappan SP.

Genomics. 1997 Jan 1;39(1):95-8.

PMID:
9027491
47.

Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate.

Jiang H, Lin J, Young SM, Goldstein NI, Waxman S, Davila V, Chellappan SP, Fisher PB.

Oncogene. 1995 Sep 21;11(6):1179-89.

PMID:
7566979
48.

Cloning and characterization of human DP2, a novel dimerization partner of E2F.

Zhang Y, Chellappan SP.

Oncogene. 1995 Jun 1;10(11):2085-93.

PMID:
7784053
49.

Interactions of the p107 and Rb proteins with E2F during the cell proliferation response.

Schwarz JK, Devoto SH, Smith EJ, Chellappan SP, Jakoi L, Nevins JR.

EMBO J. 1993 Mar;12(3):1013-20.

50.

The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.

Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR.

Genes Dev. 1992 Feb;6(2):177-85.

Supplemental Content

Loading ...
Support Center